BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 36599972)

  • 1. IGF2BP2 promotes the progression of colorectal cancer through a YAP-dependent mechanism.
    Cui J; Tian J; Wang W; He T; Li X; Gu C; Wang L; Wu J; Shang A
    Cancer Sci; 2021 Oct; 112(10):4087-4099. PubMed ID: 34309973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression.
    Zhang Q; Fan H; Zou Q; Liu H; Wan B; Zhu S; Hu Y; Li H; Zhang C; Zhou L; Zhu Q; Xiao K; Zhang J; Zhan P; Lv T; Song Y
    J Cell Mol Med; 2018 Jul; 22(7):3560-3571. PubMed ID: 29667772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.
    Wang C; Nie Z; Zhou Z; Zhang H; Liu R; Wu J; Qin J; Ma Y; Chen L; Li S; Chen W; Li F; Shi P; Wu Y; Shen J; Chen C
    Oncotarget; 2015 Jul; 6(19):17685-97. PubMed ID: 25970772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric cancer cells by activating PKMYT1.
    Zhan L; Wu W; Yang Q; Shen H; Liu L; Kang R
    Mol Cell Probes; 2023 Dec; 72():101932. PubMed ID: 37729973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nucleolar protein NIFK accelerates the progression of colorectal cancer via activating MYC pathway.
    Xia T; Wang B; Sun L
    Biosci Biotechnol Biochem; 2023 Dec; 88(1):26-36. PubMed ID: 37950567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Epigenetic and Molecular Analysis Reveals a Novel Promoter for a New Isoform of the Transcription Factor TEAD4.
    Rashidiani S; Mamo G; Farkas B; Szabadi A; Farkas B; Uszkai V; Császár A; Brandt B; Kovács K; Pap M; Rauch TA
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of RNA-Seq data using self-supervised learning for vital status prediction of colorectal cancer patients.
    Padegal G; Rao MK; Boggaram Ravishankar OA; Acharya S; Athri P; Srinivasa G
    BMC Bioinformatics; 2023 Jun; 24(1):241. PubMed ID: 37286944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEAD4: A key regulator of tumor metastasis and chemoresistance - Mechanisms and therapeutic implications.
    Liu M; Hu W; Meng X; Wang B
    Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189050. PubMed ID: 38072284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer.
    Li Q; Tong D; Jing X; Ma P; Li F; Jiang Q; Zhang J; Wen H; Cui M; Huang C; Zhang M
    Cancer Gene Ther; 2023 May; 30(5):727-737. PubMed ID: 36599972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of MAD2L1 by miR-515-5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells.
    Ding X; Fu Q; Chen W; Chen L; Zeng Q; Zhang S; He L
    Cell Biol Int; 2022 May; 46(5):840-848. PubMed ID: 35143103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
    Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
    Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The YAP-TEAD4 complex promotes tumor lymphangiogenesis by transcriptionally upregulating CCBE1 in colorectal cancer.
    Song J; Dang X; Shen X; Liu Y; Gu J; Peng X; Huang Z; Hong W; Cui L; Liu CY
    J Biol Chem; 2023 Apr; 299(4):103012. PubMed ID: 36781122
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.